Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-25 @ 2:06 PM
Study NCT ID:
NCT05724004
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2023-01-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)
Sponsor:
Karolinska University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-06-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-20
First Submit QC Date:
None
Study First Post Date:
2023-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-06
Last Update Post Date:
2023-10-10
Last Update Post Date Type:
ACTUAL